In the central nervous system (CNS) peroxisomes are current in all cell varieties, particularly neurons, oligodendrocytes, astrocytes, microglia, and endothelial cells. Brain peroxisomes are smaller in measurement in contrast to peroxisomes from different tissues and are due to this fact referred to as microperoxisomes. We have established a purification process to isolate extremely purified peroxisomes from the central nervous system which might be nicely separated from the endoplasmic reticulum and mitochondria and are free of myelin contamination.
The main issue in purification of mind peroxisomes in contrast to peroxisomes from liver or kidney is the presence of massive quantities of myelin in the CNS, which leads to contamination of the subcellular fractions. Hence, the essential step of the isolation process is the elimination of myelin by the use of a sucrose gradient, since with out the elimination of myelin no vital enrichment of purified peroxisomes may be achieved. Another issue is that in mind tissue the abundance of peroxisomes decreases considerably throughout postnatal improvement. We present a detailed protocol for the isolation of peroxisomes from mouse central nervous system in addition to a protocol for the isolation of peroxisomes from the liver and kidney utilizing a steady Nycodenz gradient.
Isolation of Plasmodium berghei ookinetes in tradition utilizing Nycodenz density gradient columns and magnetic isolation.
BACKGROUND: Large scale in vitro manufacturing of the mosquito levels of malaria parasites stays elusive, with solely restricted success for full sporogonic improvement and just one report of improvement by to infective sporozoites. The preliminary step on this course of is the manufacturing, in vitro, of ookinetes from gametocytaemic blood. Methods for isolation of these ookinetes from blood cells have been described; nevertheless, as well as to yield typically being low, processing time and potential for contamination by erythrocytes stay excessive.
METHODS: This research compares two procedures for retaining mature ookinetes from blood stage cultures, while eradicating crimson blood cells and different contaminants prior to additional tradition of the parasite. The nicely established methodology of isolation on Nycodenz cushions is in contrast with a novel methodology using the innate magnetic properties of the haem pigment crystals present in the cytoplasm of ookinetes. RESULTS: Yield and viability of ookinetes had been comparable with each isolation strategies.
However, in our arms magnetic isolation produced a cleaner ookinete preparation far more rapidly. Moreover, lowering the stream charge by the magnetic column may additional improve the yield. CONCLUSION: We suggest the enrichment of an ookinete preparation prior to additional tradition being carried out utilizing the magnetic properties of Plasmodium berghei ookinetes in its place to their density. The former approach is quicker, removes extra erythrocytes, however day-to-day prices are larger.
Efficient purification of neonatal porcine gonocytes with Nycodenz and differential plating.
Gonocytes are the solely sort of germ cells current in the postnatal testis and give rise to spermatogonial stem cells. Purification of gonocytes has necessary implications for the research and manipulation of these cells and could present insights for the ongoing investigation of the male germline stem cells. To receive a pure inhabitants of gonocytes from piglet testis cells, a wide selection of Nycodenz concentrations had been investigated for density gradient centrifugation.
We additionally examined differential plating of testis cells for varied tradition durations with completely different extracellular matrix (ECM) parts (fibronectin, poly-d-lysine, poly-L-lysine, laminin and collagen Types I and IV). Gonocytes had been extremely enriched in pellets of testis cells after utilizing 17% Nycodenz centrifugation to a purity of 81±9%.
After culturing testis cells on plates precoated with completely different ECM parts for 120 min, the proportion of gonocytes elevated amongst non-adherent cells (suspended in the medium), with fibronectin or poly-D-lysine leading to the best (up to 85%) and laminin in the lowest (54%) gonocyte proportion. Combining the most promising ECM coatings (fibronectin and poly-d-lysine) and additional extension of their tradition length to 240 min didn’t enhance ultimate gonocyte purity.
However, centrifugation with 17% Nycodenz adopted by differential plating with fibronectin and poly-d-lysine coating additional purified gonocytes amongst the collected cells to >90%. These outcomes present a easy, fast and environment friendly strategy for acquiring extremely enriched populations of piglet gonocytes to be used in the research and manipulation of these germline stem cells.
Separation and dedication of nycodenz and its impurities by capillary electrophoresis
Separation and dedication of nycodenz (a new radiography reagent) and its impurities by capillary electrophoresis was investigated. Since the analytes had been polyols, Na2B4O7-H3BO3 was chosen as the buffer system. The analytes had been negatively charged by complexing with borate. Then cetyltrimethylammonium bromide was used to reverse electroosmotic mobility so as to shorten the evaluation time. 2-Propanol was added to optimize the separation additional. Acceptable outcomes of linearity, precision of corrected peak space and migration time had been obtained. The RSD(n = 6) of corrected peak space and migration time had been 0.73% and 1.4% respectively. The outcomes obtained by CE had been immediately in contrast to these obtained by excessive efficiency liquid chromatography.
Purification of mouse primordial germ cells by Nycodenz.
Primordial germ cells are necessary cells for the research of germ cell lineage. It has proved troublesome to receive extremely purified primordial germ cells for preparation of a particular antibody. In the current research, a new methodology for purifying mouse primordial germ cells was developed utilizing a Nycodenz gradient. Furthermore, the polyclonal anti-mouse primordial germ cells IgG derived from mouse primordial germ cells was ready. As this IgG reacted solely with primordial germ cells obtained at day 12.5 after mating, this antibody appeared to acknowledge the stage-specific antigen of primordial germ cells.
One motive that a steady primordial germ cell marker has not been obtained is as a result of the purity of the primordial germ cells used has been too low to put together the antibody. This new methodology represents a vital enchancment in the purification of primordial germ cells; it’s less complicated than earlier strategies, and produced mouse primordial germ cells with a purity of greater than 95%.
GNF179 (Metabolite) |
|||
HY-15980 | MedChemExpress | 50mg | EUR 2539.2 |
GNF179 (Metabolite) |
|||
T11445-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: GNF179 (Metabolite) |
GNF179 (Metabolite) |
|||
T11445-1g | TargetMol Chemicals | 1g | Ask for price |
Description: GNF179 (Metabolite) |
GNF179 (Metabolite) |
|||
T11445-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: GNF179 (Metabolite) |
GNF179 (Metabolite) |
|||
T11445-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: GNF179 (Metabolite) |
GNF179 (Metabolite) |
|||
T11445-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: GNF179 (Metabolite) |
AR-13324 M1 metabolite |
|||
HY-12798C | MedChemExpress | 50mg | EUR 2539.2 |
AR-13324 M1 metabolite |
|||
T10358L-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AR-13324 M1 metabolite |
AR-13324 M1 metabolite |
|||
T10358L-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AR-13324 M1 metabolite |
AR-13324 M1 metabolite |
|||
T10358L-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AR-13324 M1 metabolite |
AR-13324 M1 metabolite |
|||
T10358L-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AR-13324 M1 metabolite |
AR-13324 M1 metabolite |
|||
T10358L-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AR-13324 M1 metabolite |
Avacopan metabolite M1 |
|||
A264660 | Toronto Research Chemicals | 25mg | EUR 11200 |
Description: 1346623-14-0 |
Avanafil metabolite M4 |
|||
574222 | MedKoo Biosciences | 1.0mg | EUR 770 |
5-Fluoro ADB Metabolite 7 |
|||
F587258 | Toronto Research Chemicals | 250mg | EUR 3000 |
5-Fluoro ADB Metabolite 2 |
|||
F587263 | Toronto Research Chemicals | 500mg | EUR 7600 |
5-Fluoro AMB Metabolite 2 |
|||
F588295 | Toronto Research Chemicals | 100mg | EUR 7600 |
Description: 1890250-14-2 |
Avanafil metabolite M4 |
|||
T37181-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Avanafil metabolite M4 |
Avanafil metabolite M4 |
|||
T37181-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Avanafil metabolite M4 |
Avanafil metabolite M4 |
|||
T37181-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Avanafil metabolite M4 |
Avanafil metabolite M4 |
|||
T37181-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Avanafil metabolite M4 |
Avanafil metabolite M4 |
|||
T37181-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Avanafil metabolite M4 |
Docetaxel Metabolite M4 |
|||
D494410 | Toronto Research Chemicals | 0.5mg | EUR 2082 |
Description: 157067-34-0 |
Alectinib M4 metabolite |
|||
A521150 | Toronto Research Chemicals | 10mg | EUR 362 |
Description: 1256585-04-2 |
Avanafil metabolite M16 |
|||
574225 | MedKoo Biosciences | 1.0mg | EUR 705 |
Ritonavir metabolite |
|||
HY-G0009 | MedChemExpress | 50mg | EUR 1383.6 |
Niraparib metabolite M1 |
|||
HY-G0023 | MedChemExpress | 5mg | EUR 968.4 |
Lopinavir Metabolite M-1 |
|||
L469485 | Toronto Research Chemicals | 1mg | EUR 922 |
Description: 192725-39-6 |
Lopinavir Metabolite M-3/M-4 |
|||
L469490 | Toronto Research Chemicals | 1mg | EUR 496 |
Description: 357275-54-8 |
Nilotinib Metabolite 2 |
|||
N465330 | Toronto Research Chemicals | 25mg | EUR 4500 |
Description: 1807606-80-9 |
Nilotinib Metabolite 3 |
|||
N465335 | Toronto Research Chemicals | 25mg | EUR 9200 |
Description: 1807607-72-2 |
Nilotinib Metabolite 4 |
|||
N465340 | Toronto Research Chemicals | 25mg | EUR 12800 |
Description: 1807608-52-1 |
Ritonavir metabolite |
|||
T12735-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Ritonavir metabolite |
Ritonavir metabolite |
|||
T12735-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Ritonavir metabolite |
Ritonavir metabolite |
|||
T12735-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Ritonavir metabolite |
Ritonavir metabolite |
|||
T12735-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Ritonavir metabolite |
Ritonavir metabolite |
|||
T12735-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Ritonavir metabolite |
Niraparib metabolite M1 |
|||
T12229-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Niraparib metabolite M1 |
Niraparib metabolite M1 |
|||
T12229-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Niraparib metabolite M1 |
Niraparib metabolite M1 |
|||
T12229-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Niraparib metabolite M1 |
Niraparib metabolite M1 |
|||
T12229-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Niraparib metabolite M1 |
Niraparib metabolite M1 |
|||
T12229-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Niraparib metabolite M1 |
Dasatinib metabolite M6 |
|||
T37645-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Dasatinib metabolite M6 |
Dasatinib metabolite M6 |
|||
T37645-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Dasatinib metabolite M6 |
Dasatinib metabolite M6 |
|||
T37645-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Dasatinib metabolite M6 |
Dasatinib metabolite M6 |
|||
T37645-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Dasatinib metabolite M6 |
Dasatinib metabolite M6 |
|||
T37645-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Dasatinib metabolite M6 |
Lopinavir Metabolite M-1 |
|||
T39345-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Lopinavir Metabolite M-1 |
Lopinavir Metabolite M-1 |
|||
T39345-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Lopinavir Metabolite M-1 |
Lopinavir Metabolite M-1 |
|||
T39345-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Lopinavir Metabolite M-1 |
Lopinavir Metabolite M-1 |
|||
T39345-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Lopinavir Metabolite M-1 |
Lopinavir Metabolite M-1 |
|||
T39345-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Lopinavir Metabolite M-1 |
Avanafil metabolite M16 |
|||
T37180-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Avanafil metabolite M16 |
Avanafil metabolite M16 |
|||
T37180-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Avanafil metabolite M16 |
Avanafil metabolite M16 |
|||
T37180-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Avanafil metabolite M16 |
Avanafil metabolite M16 |
|||
T37180-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Avanafil metabolite M16 |
Avanafil metabolite M16 |
|||
T37180-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Avanafil metabolite M16 |
AB-CHMINACA metabolite M2 |
|||
A105995 | Toronto Research Chemicals | 25mg | EUR 1800 |
Description: 1185887-51-7 |
AB-CHMINACA Metabolite M4 |
|||
A106030 | Toronto Research Chemicals | 100mg | EUR 804 |
Description: 1271630-11-5 |
AB-FUBINACA Metabolite 3 |
|||
A112628 | Toronto Research Chemicals | 100mg | EUR 3000 |
Description: 1877243-60-1 |
rac D 617 (Verapamil Metabolite) |
|||
D100050 | Toronto Research Chemicals | 10mg | EUR 150 |
Description: 34245-14-2 |
Cocaine Metabolite ELISA |
|||
E22-HC9067 | EnoGene | 96T | EUR 495 |
Boceprevir Metabolite M4 |
|||
B674520 | Toronto Research Chemicals | 0.5mg | EUR 1068 |
Description: 816444-90-3 |
Alectinib Metabolite M1b |
|||
A521154 | Toronto Research Chemicals | 100mg | EUR 4500 |
Ticagrelor metabolite M5 |
|||
573251 | MedKoo Biosciences | 10.0mg | EUR 330 |
Lurasidone Metabolite 14283 D8 |
|||
HY-G0001S | MedChemExpress | 50mg | EUR 9976.8 |
Lurasidone metabolite 14326 |
|||
HY-G0002 | MedChemExpress | 10mg | EUR 3117.6 |
Lurasidone Metabolite 14326 D8 |
|||
HY-G0002S | MedChemExpress | 50mg | EUR 9976.8 |
Fenamidone Metabolite |
|||
F245403 | Toronto Research Chemicals | 25mg | EUR 87 |
Description: 332855-88-6 |
M9 Metabolite of Eliglustat |
|||
M760950 | Toronto Research Chemicals | 25mg | EUR 9500 |
(R)-Ramelteon Metabolite M-II |
|||
R110065 | Toronto Research Chemicals | 10mg | EUR 339 |
(S)-Ramelteon Metabolite M-II |
|||
R110070 | Toronto Research Chemicals | 10mg | EUR 1777 |
Ramelteon metabolite M-II |
|||
T12689-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Ramelteon metabolite M-II |
Ramelteon metabolite M-II |
|||
T12689-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Ramelteon metabolite M-II |
Ramelteon metabolite M-II |
|||
T12689-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Ramelteon metabolite M-II |
Ramelteon metabolite M-II |
|||
T12689-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Ramelteon metabolite M-II |
Ramelteon metabolite M-II |
|||
T12689-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Ramelteon metabolite M-II |
Lurasidone metabolite 14326 |
|||
T11893-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Lurasidone metabolite 14326 |
Lurasidone metabolite 14326 |
|||
T11893-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Lurasidone metabolite 14326 |
Lurasidone metabolite 14326 |
|||
T11893-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Lurasidone metabolite 14326 |
Lurasidone metabolite 14326 |
|||
T11893-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Lurasidone metabolite 14326 |
Lurasidone metabolite 14326 |
|||
T11893-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Lurasidone metabolite 14326 |
Cinacalcet metabolite M4 |
|||
T10814-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Cinacalcet metabolite M4 |
Cinacalcet metabolite M4 |
|||
T10814-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Cinacalcet metabolite M4 |
Cinacalcet metabolite M4 |
|||
T10814-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Cinacalcet metabolite M4 |
Cinacalcet metabolite M4 |
|||
T10814-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Cinacalcet metabolite M4 |
Cinacalcet metabolite M4 |
|||
T10814-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Cinacalcet metabolite M4 |
Tezacaftor Metabolite M1 |
|||
T254370 | Toronto Research Chemicals | 10mg | EUR 500 |
Description: 1432656-97-7 |
Ticagrelor metabolite M5 |
|||
T21059-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Ticagrelor metabolite M5 |
Ticagrelor metabolite M5 |
|||
T21059-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Ticagrelor metabolite M5 |
Ticagrelor metabolite M5 |
|||
T21059-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Ticagrelor metabolite M5 |
Ticagrelor metabolite M5 |
|||
T21059-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Ticagrelor metabolite M5 |
Ticagrelor metabolite M5 |
|||
T21059-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Ticagrelor metabolite M5 |
Lurasidone Metabolite 14283 D8 |
|||
T19406-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Lurasidone Metabolite 14283 D8 |
Lurasidone Metabolite 14283 D8 |
|||
T19406-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Lurasidone Metabolite 14283 D8 |
Lurasidone Metabolite 14283 D8 |
|||
T19406-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Lurasidone Metabolite 14283 D8 |
Lurasidone Metabolite 14283 D8 |
|||
T19406-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Lurasidone Metabolite 14283 D8 |
Lurasidone Metabolite 14283 D8 |
|||
T19406-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Lurasidone Metabolite 14283 D8 |
Lurasidone Metabolite 14326 D8 |
|||
T19407-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Lurasidone Metabolite 14326 D8 |
Lurasidone Metabolite 14326 D8 |
|||
T19407-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Lurasidone Metabolite 14326 D8 |
Lurasidone Metabolite 14326 D8 |
|||
T19407-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Lurasidone Metabolite 14326 D8 |
Lurasidone Metabolite 14326 D8 |
|||
T19407-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Lurasidone Metabolite 14326 D8 |
Lurasidone Metabolite 14326 D8 |
|||
T19407-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Lurasidone Metabolite 14326 D8 |
Label 100X100 Toxic 6 Hazard .. - EACH |
|||
C48AS | Scientific Laboratory Supplies | EACH | EUR 5.9 |
AB-CHMINACA Metabolite M1A |
|||
A105975 | Toronto Research Chemicals | 100mg | EUR 7600 |
AB-CHMINACA metabolite M3A |
|||
A106005 | Toronto Research Chemicals | 100mg | EUR 4500 |
Almotriptan Metabolite M2 |
|||
A575205 | Toronto Research Chemicals | 50mg | EUR 7600 |
Description: 603137-41-3 |
UR-144 Metabolite Antibody |
|||
abx023993-1mg | Abbexa | 1 mg | EUR 744 |
UR-144 Metabolite Antibody |
|||
abx023994-1mg | Abbexa | 1 mg | EUR 744 |
D 13223 (Flupirtine Metabolite) |
|||
D100065 | Toronto Research Chemicals | 100mg | EUR 173 |
Description: 95777-69-8 |
Albendazole metabolite |
|||
AT144 | Unibiotest | 1mg | EUR 1641.6 |
Alectinib M4 metabolite-d4 |
|||
A521152 | Toronto Research Chemicals | 10mg | EUR 543 |
Albendazole metabolite |
|||
AG144 | Unibiotest | 1 mg | EUR 627.6 |
Abiraterone metabolite 1 |
|||
HY-103687 | MedChemExpress | 10mM/1mL | EUR 1879.2 |
Zafirlukast M1 Metabolite |
|||
Z125040 | Toronto Research Chemicals | 250mg | EUR 3000 |
Description: 219583-10-5 |
Zafirlukast M6 Metabolite |
|||
Z125050 | Toronto Research Chemicals | 250mg | EUR 11200 |
Description: 219582-85-1 |
Abemaciclib metabolite M2 |
|||
T10220-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Abemaciclib metabolite M2 |
Abemaciclib metabolite M2 |
|||
T10220-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Abemaciclib metabolite M2 |
Abemaciclib metabolite M2 |
|||
T10220-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Abemaciclib metabolite M2 |
Abemaciclib metabolite M2 |
|||
T10220-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Abemaciclib metabolite M2 |
Abemaciclib metabolite M2 |
|||
T10220-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Abemaciclib metabolite M2 |
Dacomitinib metabolite M2 |
|||
T23950-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Dacomitinib metabolite M2 |
Dacomitinib metabolite M2 |
|||
T23950-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Dacomitinib metabolite M2 |
Dacomitinib metabolite M2 |
|||
T23950-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Dacomitinib metabolite M2 |
Dacomitinib metabolite M2 |
|||
T23950-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Dacomitinib metabolite M2 |
Dacomitinib metabolite M2 |
|||
T23950-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Dacomitinib metabolite M2 |
Abiraterone metabolite 1 |
|||
T13525-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Abiraterone metabolite 1 |
Abiraterone metabolite 1 |
|||
T13525-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Abiraterone metabolite 1 |
Abiraterone metabolite 1 |
|||
T13525-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Abiraterone metabolite 1 |
Abiraterone metabolite 1 |
|||
T13525-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Abiraterone metabolite 1 |
Abiraterone metabolite 1 |
|||
T13525-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Abiraterone metabolite 1 |
Tiafenacil Metabolite M-36 |
|||
T436330 | Toronto Research Chemicals | 10mg | EUR 563 |
Tiafenacil Metabolite M-56 |
|||
T436340 | Toronto Research Chemicals | 10mg | EUR 563 |
Verapamil Metabolite (D-703) |
|||
V125030 | Toronto Research Chemicals | 250mg | EUR 7600 |
Description: 67018-80-8 |
Methotrexate metabolite |
|||
T16045-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Methotrexate metabolite |
Methotrexate metabolite |
|||
T16045-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Methotrexate metabolite |
Methotrexate metabolite |
|||
T16045-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Methotrexate metabolite |
Methotrexate metabolite |
|||
T16045-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Methotrexate metabolite |
Methotrexate metabolite |
|||
T16045-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Methotrexate metabolite |
Iloperidone metabolite P88 |
|||
574203 | MedKoo Biosciences | 10.0mg | EUR 290 |
Iloperidone metabolite P95 |
|||
574220 | MedKoo Biosciences | 1.0mg | EUR 230 |
Nirmatrelvir Metabolite (M4) |
|||
N386690 | Toronto Research Chemicals | 5mg | EUR 750 |
Description: 2755812-07-6 |
MDMB-FUBINACA Metabolite M1 |
|||
M199793 | Toronto Research Chemicals | 25mg | EUR 1800 |
Abemaciclib metabolite M20 |
|||
T10738-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Abemaciclib metabolite M20 |
Abemaciclib metabolite M20 |
|||
T10738-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Abemaciclib metabolite M20 |
Abemaciclib metabolite M20 |
|||
T10738-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Abemaciclib metabolite M20 |
Abemaciclib metabolite M20 |
|||
T10738-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Abemaciclib metabolite M20 |
Abemaciclib metabolite M20 |
|||
T10738-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Abemaciclib metabolite M20 |
Tofacitinib metabolite-1 |
|||
T37638-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Tofacitinib metabolite-1 |
Tofacitinib metabolite-1 |
|||
T37638-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Tofacitinib metabolite-1 |
Tofacitinib metabolite-1 |
|||
T37638-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Tofacitinib metabolite-1 |
Tofacitinib metabolite-1 |
|||
T37638-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Tofacitinib metabolite-1 |
Tofacitinib metabolite-1 |
|||
T37638-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Tofacitinib metabolite-1 |
Iloperidone metabolite P95 |
|||
T36661-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Iloperidone metabolite P95 |
Iloperidone metabolite P95 |
|||
T36661-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Iloperidone metabolite P95 |
Iloperidone metabolite P95 |
|||
T36661-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Iloperidone metabolite P95 |
Iloperidone metabolite P95 |
|||
T36661-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Iloperidone metabolite P95 |
Iloperidone metabolite P95 |
|||
T36661-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Iloperidone metabolite P95 |
Imidafenacin Metabolite M4 |
|||
T36662-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Imidafenacin Metabolite M4 |
Imidafenacin Metabolite M4 |
|||
T36662-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Imidafenacin Metabolite M4 |
Imidafenacin Metabolite M4 |
|||
T36662-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Imidafenacin Metabolite M4 |
Imidafenacin Metabolite M4 |
|||
T36662-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Imidafenacin Metabolite M4 |
Imidafenacin Metabolite M4 |
|||
T36662-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Imidafenacin Metabolite M4 |
21x21mm Toxic GHS Symbols roll - EACH |
|||
GHSR21TO | Scientific Laboratory Supplies | EACH | EUR 113.4 |
50x50mm Toxic GHS Symbols roll - EACH |
|||
GHSR50TO | Scientific Laboratory Supplies | EACH | EUR 225.45 |
40x40mm Toxic GHS Symbols sheet - EACH |
|||
GHSC40TO | Scientific Laboratory Supplies | EACH | EUR 20.57 |
In addition, the separation reagent Nycodenz is non-toxic and achieved separation of primordial germ cells with out attachment of antibodies in opposition to the primordial germ cell membrane floor. This new purification methodology and stage-specific antibody will likely be helpful for the evaluation of the mechanisms of primordial germ cell migration.